Abstract
Dendritic cells (DC) represent the most potent antigen presenting cells and induce efficient cytotoxic T lymphocyte (CTL) responses against viral infections. Targeting antigens (Ag) to receptors on DCs is a promising strategy to enhance antitumor and antiviral immune responses induced by DCs. Here, we investigated the potential of CD11c-specific single-chain fragments (scFv) fused to an immunodominant peptide of Friend retrovirus for induction of virus-specific T cell responses by DCs. In vitro CD11c-specific scFv selectively targeted viral antigens to DCs and thereby significantly improved the activation of virus-specific T cells. In vaccination experiments DCs loaded with viral Ag targeted to CD11c provided improved rejection of FV-derived tumors and efficiently primed virus-specific CTL responses after virus challenge. Since the induction of strong virus-specific T cell responses is critical in viral infections, CD11c targeted protein vaccines might provide means to enhance the cellular immune response to prophylactic or therapeutic levels.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Antigens, Viral / chemistry
-
Antigens, Viral / immunology*
-
CD11c Antigen / immunology*
-
Cell Line, Tumor
-
Cell Proliferation
-
Dendritic Cells / immunology*
-
Female
-
Immunization
-
Immunodominant Epitopes / chemistry
-
Immunodominant Epitopes / immunology
-
Lymphocyte Activation / immunology
-
Mice
-
Mice, Inbred C57BL
-
Molecular Sequence Data
-
Ovalbumin / immunology
-
Recombinant Fusion Proteins / metabolism
-
Retroviridae / immunology*
-
Single-Chain Antibodies / chemistry
-
Single-Chain Antibodies / immunology
-
Species Specificity
-
Spleen / cytology
-
T-Lymphocytes, Cytotoxic / immunology*
-
T-Lymphocytes, Cytotoxic / virology*
-
env Gene Products, Human Immunodeficiency Virus / immunology
-
gag Gene Products, Human Immunodeficiency Virus / immunology
Substances
-
Antigens, Viral
-
CD11c Antigen
-
Immunodominant Epitopes
-
Recombinant Fusion Proteins
-
Single-Chain Antibodies
-
env Gene Products, Human Immunodeficiency Virus
-
gag Gene Products, Human Immunodeficiency Virus
-
Ovalbumin
Grants and funding
The authors are supported by grants of the Austrian Science Fund (FWF): P21508-B13 to ZB, the 6th frame work of the EU (DEC-VAC 2005-018685 to HS), and the Federal Government of Tyrol (Tiroler Wissenschaftsfonds TWF-2008-1-562 to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.